Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2025 10:40 ET | Source: Research and Markets

Enhertu Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2024, 2024-2029, 2034F

Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Enhertu Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
October 31, 2024 10:00 ET | Source: Seno Medical

Real World Use of OA Imaging Confirms Clinical Acceptability of Second Generation Imagio® Breast Imaging System

San Antonio, TX, Oct. 31, 2024 (GLOBE NEWSWIRE) -- A study published in Academic Radiology, Exploring the Utility of Optoacoustic Imaging in Differentiation of Benign and Malignant Breast Masses:...
September 04, 2024 10:39 ET | Source: Research and Markets

Europe Breast Cancer Screening Market Forecast Report and Company Analysis 2024-2032 Featuring AstraZeneca, Novartis, Sanofi, Pfizer, Bayer, and GlaxoSmithKline

Dublin, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The "Europe Breast Cancer Screening Market Forecast Report by Europe Breast Cancer Screening Market, Countries, and Company Analysis, 2024-2032" report has...
March 26, 2024 18:10 ET | Source: Research and Markets

Global Interventional Oncology Devices Market Targets Growth to $3.25 Billion by 2028

Dublin, March 26, 2024 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Market Expansion Driven by...
February 13, 2024 10:00 ET | Source: Seno Medical

American Medical Association Issues New CPT Code for Use of Seno Medical’s Opto-acoustic Technology in Breast Cancer Diagnosis

San Antonio, TX, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The American Medical Association (AMA) has issued a new Category III Current Procedural Terminology (CPT*) code for the use of Imagio® (OA/US)...
March 23, 2023 09:30 ET | Source: Seno Medical

Seno Medical’s SenoGram® Decision Support Tool Named Winner in 2023 Artificial Intelligence Excellence Awards

San Antonio, TX, March 23, 2023 (GLOBE NEWSWIRE) -- The Artificial Intelligence Excellence Awards program has selected Seno Medical’s AI platform, SenoGram® — exclusively available in conjunction...
November 18, 2020 02:48 ET | Source: Balboa Press

New book shares one woman’s experiences, insights and perspectives gleaned from navigating a genetically driven breast cancer diagnosis

SHAKER HEIGHTS, Ohio, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Penny Casselman marks her publishing debut with the release of “How To Get A Free Boob Job” (published by Balboa Press). With sprinkles of...
March 05, 2012 09:48 ET | Source: Atossa Genetics, Inc.

Atossa Genetics' National Reference Laboratory for Breast Health Receives CLIA Certification

SEATTLE, WA--(Marketwire - Mar 5, 2012) - Atossa Genetics, Inc., a private healthcare company focused on the prevention of breast cancer through the commercialization of diagnostic tests that can...